Due to the inhibitory effects of bromocriptine on CREBZF, biological functions of CREBZF may give clues to expand indications of bromocriptine in various diseases such as NAFLD and NASH. Here, CREBZF is linked to metabolic dysfunction-associated steatotic liver disease.